🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If CGR is not a challenge, shld all pts with 1st platin sens recurrence be offered sCRS? Role of sCRS in the era of PARPi & bev? esp with ⬆️⬆️ pts getting these in 1st line Rx Sharing our combined wisdom glen sanket sharad mehta degruyter.com/document/doi/1… De Gruyter Brill ➡️ @degruyterbrill.bsky.social

Patient-reported outcomes after multi-visceral pelvic resections and reconstructions for advanced rectal cancers - Read our study pubmed.ncbi.nlm.nih.gov/38288783/ ASCRS_1 @ACPGBI European Society of Coloproctology ISUCRS European Society of Surgical Oncology (ESSO) Colorectal Disease KSERS 2024 (KSERS 2024) Tata Memorial Hospital ACTREC-TMC PelvEx

Lately, more and more scientific journals are stablishing APC (article proccessing charge). For many researchers this is another obstacle in our way to get our work published... 😅 In this thread I´ll gather Ob&G journals where you can publish your Gynonc work for free: 🧵🧵🧵

📢 BGCS & The British Assoc of Gynaecological Pathology consensus for #germline & #tumor testing for #BRCA1/2 variants in #OvarianCancer setting a new #standard for personalized care in the #UK 🇬🇧 @ bit.ly/3Xxu4XN Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO

Aditi Bhatt 🇮🇳, Artem Stepanyan 🇦🇲 & Olivier Glehen 🇫🇷 will present the newly developed PSOGI-ESGO-ISSPP international consensus statement on cytoreductive surgery for peritoneal malignancies at the PSOGI-ISSPP 2024 congress in Lyon this month. The manuscript aims to, among

Happy and proud to share that our hard work has been recognised. we are now accredited as a center for advanced ovarian cancer surgery! by ESGO ESGO OncoAlert Tata Trusts Anik Ghosh #OncoDaily #teamworkmakesthedreamwork

It takes a lot of patience and hardwork with unending dedication to achieve a milestone which is unique and path breaking. Our ESGO accreditation for ovarian cancer surgery is the first one in the country and a testament to the impeccable teamwork at Tata Medical Center

Doing more with less !! Minimally invasive CRS by Mufaddal Kazi. Spellbound audience. But is MIS seeing everything? Aditi Bhatt leads the discussion with our prospective multicentre cohort study. Get in touch if you'd like to collaborate #COPS2025

🚀 SUROVA is the largest global real-world study on advanced ovarian cancer, and these are its conclusions. #ESGO #SUROVA #OvarianCancer #GlobalStudy #Oncology #RealWorldData #IGCS

Save the date for the next two webinars in our popular series on the updated ESGO-ESTRO-ESP Endometrial Cancer Management Guidelines!🧑‍💻 🔶 May 22 🔶 June 24 Register on the ESGO eAcademy 🙌 #oncoalert #gynonc

This is a call for video for the upcoming Surgical Mentorship webinar which will be held in June. The deadline for sending the videos is on May 1st. Please send a video to [email protected] The registration is open o eAcademy: buff.ly/cr1xMRK

🐣 🌟 *Crack open* new horizons in peritoneal oncology! Join Dr. Ramakrishnan AS and global experts at 9th INDEPSO-ISPSM Annual update **MVR CANCON 2025**🐰📅 June 4–7, 2025 📍 Kozhikode Featuring 🥚 Pre-conference video workshop by Prof Paul Sugarbaker 🥚 Sessions on

Anesthesia and Critical Care teams are vital in CRS & HIPEC outcomes. 🏥 At the 9th Annual Update *MVR CANCON 2025*, we're dedicating an entire day to mastering the nuances of peri-operative care. 📅 June 6 | 📍 Kozhikode, India …onealupdate2025.mvrcancerhospital.com

Very important work from Christian Dagher and team looking at molecular subtypes and genomic landscape of undiff/dediff endometrial cancer. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

🚨 New INDEPSO–ISPSM Consensus on Ovarian Cancer just published! 📝 link.springer.com/article/10.100… CRS & HIPEC are redefining survival outcomes in advanced/recurrent ovarian cancer. Join the conversation at #MVRCancon2025 — with dedicated sessions on Ovarian Cancer this year. 📅

Young Oncologists Group India🇮🇳 SoMe4Peritoneum IASO Academics IJGC IJGC Fellows SoMe4GynOnc GYN Cancer | #GYNCSM RarasNoInvisibles glen Paul H Sugarbaker sanket sharad mehta Dr. Zeeba Usofi. MS, DrNB Ambarish Chatterjee Prasanth Penumadu Praveen Kammar Anik Ghosh Aarthi S Jayraj Swapnil Patel Pseudomyxoma Survivor GECOP

Don’t let docs explain away your symptoms if they persist

A warm 🌞 and endearing ☺️ message from Kurt Van der Speeten reinforcining why all peritoneal surface oncology specialists in the region 🌍🌏🌍🇮🇳🇱🇰🇨🇳🇧🇩🇲🇾🇳🇵 🪫less experienced- improve your knowledge and understanding ⚡️more experienced- exchange experiences, outcomes and discuss the

Combined conclusions from SUROVA + TRUST: ✅ Primary surgery gives the best long-term outcomes — if done safely ✅ NACT is a solid alternative in high-risk patients 🚨 But surgical complications are the game changer #Esgo #Igcs Enrique Chacón